Sign In
Buy SAGE
$8.68
+0 (+0%)
At Close: Oct 30, 2025
Levi & Korsinsky Notifies Shareholders of Sage Therapeutics, Inc.(SAGE) of a Class Action Lawsuit and an Upcoming Deadline
09:20pm, Tuesday, 10'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
SAN DIEGO--(BUSINESS WIRE)---- $SAGE #SageTherapeuticsInc--Robbins LLP is Investigating Allegations that Sage Therapeutics, Inc. (SAGE) Misled Investors Regarding the Efficacy of its New Drugs.
Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – SAGE
04:15pm, Tuesday, 10'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
NEW YORK , Sept. 10, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed ag
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sage Therapeutics, Inc. (NASDAQ: SAGE) between April 12, 2021 a
Shareholders that lost money on Sage Therapeutics, Inc. (SAGE) Urged to Join Class Action – Contact The Gross Law Firm to Learn More
01:20pm, Tuesday, 10'th Sep 2024
NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Sage Therapeutics, Inc. (NASDAQ: SAGE).
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc.(SAGE) Shareholders
11:30am, Tuesday, 10'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
The Schall Law Firm Urges Public Participation In A Case For Securities Fraud Against Sage Therapeutics Inc
11:00am, Tuesday, 10'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sage Therapeutics, Inc. ("Sa
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securiti
SAGE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Sage Therapeutics, Inc. to Contact the Firm Today!
07:00am, Tuesday, 10'th Sep 2024
NEW YORK CITY, NY / ACCESSWIRE / September 10, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sage T
Sage Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - SAGE
05:45am, Tuesday, 10'th Sep 2024
NEW YORK , Sept. 10, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sage Therapeutics, Inc. ("Sage Therapeutics" or the "Company") (NASDAQ: SAGE) of a class action securities lawsui
Shareholders of Sage Therapeutics, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights – SAGE
11:55pm, Monday, 09'th Sep 2024
NEW YORK, NY / ACCESSWIRE / September 9, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securitie
NEW YORK CITY, NY / ACCESSWIRE / September 6, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sage Th
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sage Therapeutics, Inc. ("Sag
